Werewolf Therapeutics Inc (HOWL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
Werewolf Therapeutics Inc (HOWL) Competitors
The companies most similar to Werewolf Therapeutics are Elicio Therapeutics (ELTX), Plus Therapeutics (PSTV) and Oncolytics Biotech (ONCY). By market cap, Werewolf Therapeutics ranks 5th of the 13 companies on this page; Tiziana Life Sciences (TLSA) is the largest at $72.53M.
Peer Comparison
HOWL's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| Elicio Therapeutics Inc. (ELTX) | $42.46M | N/A | N/A | 0.0% | -96.6% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $42.93M | N/A | 7.8x | 0.0% | -96.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Werewolf Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Elicio Therapeutics Inc. (ELTX) | Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment. | ELTX competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... |
Frequently Asked Questions About HOWL
Who are Werewolf Therapeutics' main competitors?
The companies most similar to Werewolf Therapeutics include Elicio Therapeutics (ELTX), Plus Therapeutics (PSTV), Oncolytics Biotech (ONCY), Gain Therapeutics (GANX) and Connect Biopharma Holdings (CNTB), listed from the closest match.
Who is Werewolf Therapeutics' biggest competitor?
Tiziana Life Sciences (TLSA) is the largest of the similar companies at $72.53M; Elicio Therapeutics (ELTX) is the closest match by business profile, size, sector and industry.
How does HOWL stock compare with its competitors?
HOWL's P/S is 2.3x against a peer median of 7.8x; its net margin is -164.8% against a peer median of 0.0%.
Which of Werewolf Therapeutics' competitors pays a higher dividend?
Werewolf Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Werewolf Therapeutics bigger than its competitors?
No. Werewolf Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Tiziana Life Sciences (TLSA) at $72.53M.
HOWL pages: Overview, Earnings, Forecast, Financials, Competitors